China NT Pharma Group Co., Ltd. (HK:1011) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
China NT Pharma Group Co., Ltd. has terminated a significant acquisition regarding the commercialization rights due to technical issues and a change in the company’s focus towards its core bone health business. Additionally, the company announced a reallocation of the unused HK$2.9 million from the net proceeds of a recent share placing, which will now be directed towards working capital and general corporate purposes to improve financial flexibility.
For further insights into HK:1011 stock, check out TipRanks’ Stock Analysis page.